Hyperthermia cancer treatment involves elevating the temperature of malignant tumors to damage and kill cancer cells or sensitize them to other treatments like chemotherapy and radiation therapy. It has emerged as an effective approach to treat various types of cancer like breast, lung and liver cancer with minimal side effects. The use of hyperthermia helps kill cancer cells without harming normal cells and tissues. This technology allows for precise temperature control and monitoring to effectively eliminate cancerous tissues locally or throughout the entire body.
The global Hyperthermia Cancer Treatment Market is estimated to be valued at US$ 187.05 Bn in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increased demand for minimally invasive cancer therapies is a major trend driving the hyperthermia cancer treatment market. Traditional cancer therapies such as chemotherapy and radiation therapy often cause severe side effects and diminish the overall quality of life of patients. Hyperthermia treatment allows effective treatment of localized tumors with minimal damage to surrounding normal tissues. It reduces complications and helps improve treatment outcomes. Furthermore, technological advancements enabling precise temperature control, real-time monitoring and focused energy deposition have increased the adoption of hyperthermia systems globally. New product launches with integrated thermo-therapy systems offering personalized treatment protocols are also expected to support market growth over the forecast period.
Strength: Hyperthermia cancer treatment offers minimal side effects and can be used with other cancer therapies like chemotherapy or radiation therapy. It is a non-invasive treatment option for cancer patients.
Weakness: Maintaining required temperature in the tumor tissues is challenging with hyperthermia treatment. There is also a lack of skilled professionals for this treatment.
Opportunity: Rising incidences of cancer and the focus on alternative treatment options present growth opportunities for hyperthermia cancer treatment. Growing demand for minimally invasive procedures also supports market growth.
Threats: Availability of other effective cancer treatment options like chemotherapy, immunotherapy, targeted therapy limits the demand for hyperthermia treatment. High installation and maintenance costs of equipment also restrict market growth.
The Global Hyperthermia Cancer Treatment Market Growth is expected to witness high growth over the forecast period of 2023 to 2030. The market size for 2023 is valued at US$ 187.05 billion.
The Asia Pacific region dominates the global market and is projected to grow at the fastest rate during the forecast period. Growing incidences of cancer and rising healthcare expenditure in developing countries like China and India support market growth in this region.
Key players operating in the hyperthermia cancer treatment market are MagForce AG, Andromedic, Xianke Medical Equipment, OncoTherm, Celsius42+, Oncotherm, Pyrexar Medical, Yamamoto Vinita, Nanoprobes, Alba Hyperthermia System, Nova Company, Perseon, Omron, Sunny Medical Equipment, OrienTech, BSD Medical, Sensius, Celsius42, Nanjing Greathope, Shanghai Huayuan. These companies are focusing on new product launches and geographical expansions to strengthen their market presence.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it